Ferrostatin-1 attenuates ferroptosis and protects the retina against light-induced retinal degeneration

Degenerative retinal diseases, including age-related macular degeneration, are serious diseases that may lead to irreversible retinal neuron damage and permanent vision impairment. There are currently no effective treatments for these diseases due to our incomplete understanding of the underlying pathological mechanisms. Ferroptosis, a newly identified iron-dependent mode of cell death, is implicated in various diseases. However, it is unknown whether ferroptosis is involved in light-induced retinal degeneration. In this study, we found that light exposure significantly reduced the viability of photoreceptor cells in vitro and induced pro-ferroptotic changes, including iron accumulation, mitochondrial shrinkage, glutathione depletion, increased malondialdehyde (MDA), and decreased protein expression of SLC7A11 and GPX4. The effects of light exposure on ferroptosis were attenuated by ferrostatin-1. Consistently, the results of in vivo studies demonstrated that ferrostatin-1 protected against light induced ferroptosis. And it exerted therapeutic effects by inhibiting neuroinflammation and prevented the effects of light exposure on the structure and function of the retina. The findings reveal an important role of ferroptosis in the pathogenesis of light-induced retinal degeneration and suggest that ferroptosis may be a novel treatment target for preventing retinal degeneration. (c) 2021 Elsevier Inc. All rights reserved.

Automated summary

The study revealed that light exposure induced pro-ferroptotic changes in photoreceptor cells, suggesting the involvement of ferroptosis in light-induced retinal degeneration. Treatment with ferrostatin-1 alleviated the effects of light-induced ferroptosis and protected the retina from damage, indicating its potential as a novel therapeutic target for preventing retinal degeneration.